多模式图像引导的酶/原药癌症治疗
Cong Li1, Paul T Winnard, Tomoyo Takagi
1JHU ICMIC Program, The Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
Journal of the American Chemical Society
|November 23, 2006
概括
研究人员开发了一种细菌细胞因子去氨酶 (bCD) 和聚-l-氨酸 (PLL) 的新型结合物,用于向癌症治疗. 这种结合物显示出在乳腺癌治疗中增强药物输送和成像效果的前景.
科学领域:
- 生物结合化学 生物结合化学
- 分子成像分子成像技术
- 酶工程是什么? 酶工程是什么?
背景情况:
- 细菌细胞因子脱氨酶 (bCD) 是一种用于癌症治疗中用于前药激活的酶.
- 聚-l-氨酸 (PLL) 是一种聚合物载体,可以增强药物输送和细胞吸收.
- 像Gd3+-DOTA这样的成像剂的功能化允许磁共振成像 (MRI).
研究的目的:
- 合成和表征一种新的bCD和PLL生物结合物,该生物结合物与生物素,罗达胺和Gd3+-DOTA功能化.
- 评估结合剂在癌症治疗和成像中潜在使用的特性.
- 评估结合物的酶活性,特异性,细胞毒性,细胞吸收和稳定性.
主要方法:
- 化学合成和bCD-PLL结合物的表征.
- 在体外酶活性和特异性测定中使用5 - 化素.
- 对癌细胞系的细胞毒性测定.
- 使用光显微镜进行细胞吸收研究.
- 在小鼠血清和细胞培养中进行酶稳定性测试.
主要成果:
- 合成的bCD-PLL结合物表现出高的放松性,表明良好的MRI对比潜力.
- 观察到对前药物5 - 光细胞素的增强酶特异性.
- 结合物显示出低细胞毒性和癌细胞中有效的细胞吸收.
- 在新鲜小鼠血清和人类乳腺癌细胞培养物中都保持了高酶稳定性.
结论:
- 这种新型的bCD-PLL合物在癌症治疗中具有显著的治疗应用潜力.
- 它的特性表明,它可以提高针对性前药物激活和成像的疗效和安全性.
- 需要进一步的研究来探索其体内性能和治疗指数.
更多相关视频
12:23Multi-modal Imaging of Angiogenesis in a Nude Rat Model of Breast Cancer Bone Metastasis Using Magnetic Resonance Imaging, Volumetric Computed Tomography and Ultrasound
Published on: August 14, 2012
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
相关概念视频
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...